ERICKA FLIPPING: Open Payments
NPI 1225344534 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 85 payments from 18 companies in 2025. Trend: 2023 $611 · 2024 $1,051 · 2025 $2,638
Food & beverage: $2,554Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $847 |
| ABBVIE INC. | 17 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $256 |
| Madrigal Pharmaceuticals | 4 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $178 |
| Ardelyx, Inc. | 10 | $176 |
| Ipsen Biopharmaceuticals, Inc | 1 | $147 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 5 | $94 |
| GENZYME CORPORATION | 2 | $57 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, XIFAXAN, IBSRELA, IQIRVO, MAVYRET, ZENPEP.
Industry payments across NC — which companies pay providers there.
